Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19
Clinical trial NCT04646031 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04646031
- Sponsor
- Tasly Pharmaceuticals, Inc.
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.